Apex Kidney Care Secures $9 Mn Investment to Strengthen Kidney Care Accessibility in India

This investment, facilitated by Tata Capital Healthcare Fund (TCHF), aims to improve the accessibility and quality of kidney care in India, particularly in underserved areas.

Mumbai-based Apex Kidney Care (AKC) has received $9 million in Foreign Direct Investment (FDI) from Blue Earth Capital AG, a Switzerland-based global impact investment firm, for an undisclosed equity stake.

This investment, facilitated by Tata Capital Healthcare Fund (TCHF), aims to improve the accessibility and quality of kidney care in India, particularly in underserved areas.

The $9 million investment is set to support AKC in expanding its comprehensive services for kidney disease patients, with a strong focus on automation and quality care.

This partnership between Blue Earth Capital AG and Tata Capital Healthcare Fund underscores a shared commitment to addressing the growing demand for high-quality dialysis services in India.

Visalakshi Chandramouli, Managing Partner at Tata Capital Healthcare Fund II, said, “This collaboration highlights our shared commitment to meeting the growing need for accessible, high-quality dialysis care in India. Co-investments remain a vital part of TCHF’s strategy, providing portfolio companies with enhanced access to growth capital and opportunities.”

AKC’s Vision for the Future of Kidney Care

Dr Shrirang Bichu, co-founder of AKC, emphasized the significance of the new investment and its alignment with AKC's mission.

“We are delighted to welcome BlueEarth as our Investor Partner. Together with TCHF and BlueEarth, we will continue our mission to expand and strengthen our comprehensive ecosystem for kidney disease patients. BlueEarth’s and TCHF’s confidence in our business ethics and philosophy is a great source of motivation for our team. We remain committed to driving growth by enhancing accessibility, with a strong focus on automation and quality. We will achieve this by collaborating with like-minded clinicians and hospitals, as well as partnering with government through PPP programs,” said Dr Bichu.

A Focus on Impactful Healthcare Delivery

Rohan Ghose, Director of Private Equity Partnerships at BlueEarth, highlighted the social impact this investment would have on rural and semi-urban areas.

“By focusing on semi-urban and rural areas in India, AKC addresses a critical gap in healthcare delivery. What sets AKC apart is its commitment to clinical excellence and patient safety. Through this investment, we are partnering with a mission-driven organization while creating meaningful social impact by improving access to life-saving dialysis treatment for underserved populations,” Ghose remarked.